Hamid R Khatibi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 730 W. Market St., Lima, OH 45801 Phone: 419-226-4310 Fax: 419-226-4315 |
Jennifer Lynne Whitehead, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 830 W High St Ste 102, Lima, OH 45801 Phone: 419-222-4045 Fax: 419-228-5665 |
Aakash Kumar, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-226-4310 Fax: 419-226-4315 |
Patrice Scipio, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-226-4310 Fax: 419-226-4315 |
Jessica Walters, APRN-CNP Hospitalist Medicare: Medicare Enrolled Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-227-3361 |
News Archive
Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found.
Republican Newt Gingrich, who has positioned himself as the idea guy in this presidential campaign, will today call for Americans to have new choices in how they buy health insurance, pay their income taxes and save for retirement. In his '21st Century Contract with America' that he shared with The Des Moines Register and will officially release Thursday in Iowa, Gingrich says people should to be able to choose either a tax credit or the ability to deduct the value of their health insurance up to a certain amount.
Angiotech Pharmaceuticals, Inc. today announced that it has reached an agreement (the "Second Extension Agreement") with the holders (the "Consenting Noteholders") of a majority of the outstanding 7.75% Senior Subordinated Notes (the "Subordinated Notes") to extend certain deadlines outlined in the previously announced Recapitalization Support Agreement dated October 29, 2010 and amended on November 29, 2010 (as amended, the "Support Agreement").
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces today that it has granted an aggregate of 175,000 stock options at an exercise price of $0.15 per common share, to the President & CEO of the Company.
› Verified 4 days ago